Markel announces completion of MECO acquisition

Markel Insurance, the insurance operations within Markel Group Inc. (NYSE:MKL), today announced that it has completed its acquisition of specialist marine MGA, The MECO Group Limited (MECO), following regulatory approvals. https://mma.prnewswire.com/media/2090808/Markel_primary_logo_Logo.jpg Andrew McMellin, President of Markel International, stated: “We're thrilled to finalise this acquisition and officially welcome MECO's people to Markel. MECO is a well-regarded […]

ZBIO INVESTOR ALERT: Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to Zenas BioPharma's registration statement issued in connection with Zenas BioPharma's initial public offering (“IPO”) held on or around September 13, 2024, and were damaged thereby, have until June 16,

ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – ZBIO

The DJS Law Groupreminds investors of a class action lawsuit against Zenas Biopharma, Inc. (“Zenas” or “the Company”) (NASDAQ: ZBIO) for violations of the federal securities laws. https://mma.prnewswire.com/media/2700865/DJS.jpg Shareholderswho purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering (“IPO”) conducted on September 13, 2024,

CME Group Announces Record Volume, Open Interest Across Battery Metals Complex

CME Group, the world's leading derivatives marketplace, today announced record volume and open interest across its battery metals complex. A total of 2,587 contracts were traded across battery metals futures and options on May 29, surpassing the previous record of 2,301 contracts set on February 11, 2025. Combined open interest also reached an all-time high

Illumio Simplifies Zero Trust in Critical Infrastructure with NVIDIA Accelerated Computing

SUNNYVALE, Calif., June 02, 2025 (GLOBE NEWSWIRE) — Illumio Inc., the breach containment company, today announced a strategic integration with NVIDIA to help critical infrastructure organizations strengthen protections and advance their Zero Trust posture. The collaboration integrates the NVIDIA BlueField networking platform with Illumio's breach containment platform, delivering robust security and operational efficiency across converged

Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 Development

MELBOURNE, Australia and OXFORD, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) — Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifying immunotherapies for food allergy, today announces the appointment of Louise Peacock as Chief Regulatory and Quality Officer, based at the Company's Oxford, UK site. With more than 35 years in the pharmaceutical industry, Louise brings

Press Release Biocartis NV: Biocartis Announces IVDR Class C CDx Certification of the Idylla(TM) EGFR Mutation Test

PRESS RELEASE 02/06/2025, 10:00 CEST Biocartis Announces IVDR Class C CDx Certification of the Idylla(TM) EGFR Mutation Test Mechelen, Belgium, 02 June 2025 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce that its Idylla(TM) EGFR Mutation Test has received the European Union (EU) Technical Documentation Assessment and Quality Management System

Press Release Biocartis NV: Biocartis Announces IVDR Class C CDx Certification of the Idylla(TM) EGFR Mutation Test

Press Release Biocartis NV: Biocartis Announces IVDR Class C CDx Certification of the Idylla(TM) EGFR Mutation Test GlobeNewswire June 02, 2025 PRESS RELEASE 02/06/2025, 10:00 CEST Biocartis Announces IVDR Class C CDx Certification of the Idylla(TM) EGFR Mutation Test Mechelen, Belgium, 02 June 2025 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased

Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 Development

Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 Development GlobeNewswire June 02, 2025 MELBOURNE, Australia and OXFORD, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) — Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifying immunotherapies for food allergy, today announces the appointment of Louise Peacock as Chief Regulatory

Illumio Simplifies Zero Trust in Critical Infrastructure with NVIDIA Accelerated Computing

Illumio Simplifies Zero Trust in Critical Infrastructure with NVIDIA Accelerated Computing Integration of Illumio Platform with NVIDIA BlueField DPUs delivers robust Zero Trust solution across converged IT/OT environments and high-performance computing GlobeNewswire June 02, 2025 SUNNYVALE, Calif., June 02, 2025 (GLOBE NEWSWIRE) — Illumio Inc., the breach containment company, today announced a strategic integration with

Scroll to Top